304 related articles for article (PubMed ID: 20535156)
21. What is clinical utility and why should we care?
Lesko LJ; Zineh I; Huang SM
Clin Pharmacol Ther; 2010 Dec; 88(6):729-33. PubMed ID: 21081937
[No Abstract] [Full Text] [Related]
22. Epidermal growth factor receptor inhibitors: current status and future directions.
Chen HX; Cleck JN; Coelho R; Dancey JE
Curr Probl Cancer; 2009; 33(4):245-94. PubMed ID: 20082842
[No Abstract] [Full Text] [Related]
23. Ode to a past emperor.
Di Leo A; Oakman C
J Clin Oncol; 2010 Jun; 28(18):2938-40. PubMed ID: 20479406
[No Abstract] [Full Text] [Related]
24. Personalizing medicine for the child with heart disease: a path forward.
Mital S
J Cardiovasc Pharmacol; 2011 Jul; 58(1):1-3. PubMed ID: 21654326
[No Abstract] [Full Text] [Related]
25. Research in general practice in New Zealand.
Reid J
N Z Med J; 2003 Nov; 116(1186):U679. PubMed ID: 14657962
[No Abstract] [Full Text] [Related]
26. [Status of clinical trials in oncology--2013 and onwards].
Wörmann B; Freund M; Overkamp F; Ehninger G
Onkologie; 2013; 36 Suppl 2():3-8. PubMed ID: 23549030
[TBL] [Abstract][Full Text] [Related]
27. Networks medicine: from reductionism to evidence of complex dynamic biomolecular interactions.
Roukos DH
Pharmacogenomics; 2011 May; 12(5):695-8. PubMed ID: 21619431
[No Abstract] [Full Text] [Related]
28. Research reporting and evidence of effectiveness: why "no difference" matters.
Hackbarth D
Am J Crit Care; 2008 May; 17(3):218-20. PubMed ID: 18450678
[No Abstract] [Full Text] [Related]
29. [Individualized medicine and what journalists can do to build a more realistic picture].
Koch K
Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):23-8. PubMed ID: 22325104
[TBL] [Abstract][Full Text] [Related]
30. Clinical drug tests adapted for speed.
Ledford H
Nature; 2010 Apr; 464(7293):1258. PubMed ID: 20428134
[No Abstract] [Full Text] [Related]
31. New platforms aim to obliterate silos of participatory science.
Dolgin E
Nat Med; 2014 Jun; 20(6):565-6. PubMed ID: 24901553
[No Abstract] [Full Text] [Related]
32. [Clinical trials and personalized medicine in oncology?].
Arnold D; Bokemeyer C
Onkologie; 2010; 33 Suppl 7():25-9. PubMed ID: 20926911
[TBL] [Abstract][Full Text] [Related]
33. Clinical prediction rules: new opportunities for pharma.
Herscu P; Hoover TA; Randolph AG
Drug Discov Today; 2009 Dec; 14(23-24):1143-9. PubMed ID: 19853059
[TBL] [Abstract][Full Text] [Related]
34. Hotel-based rheumatology, and more.
Leeb BF
J Rheumatol; 2009 Feb; 36(2):455-6; author reply 456-7. PubMed ID: 19208582
[No Abstract] [Full Text] [Related]
35. Big data in biomedicine.
Bender E
Nature; 2015 Nov; 527(7576):S1. PubMed ID: 26536215
[No Abstract] [Full Text] [Related]
36. Variance estimation in clinical studies with interim sample size re-estimation.
Miller F
Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681
[TBL] [Abstract][Full Text] [Related]
37. Expectations, validity, and reality in omics.
Ioannidis JP
J Clin Epidemiol; 2010 Sep; 63(9):945-9. PubMed ID: 20573481
[TBL] [Abstract][Full Text] [Related]
38. The changing landscape of urologic oncology: initiating systemic therapies, interventional skills, and clinical trials. Introduction.
Lin DW; Shore ND
Urol Oncol; 2012; 30(4 Suppl):S1. PubMed ID: 22795074
[No Abstract] [Full Text] [Related]
39. Dealing with the evidence dilemma in genomics and personalized medicine.
Khoury MJ
Clin Pharmacol Ther; 2010 Jun; 87(6):635-8. PubMed ID: 20485318
[TBL] [Abstract][Full Text] [Related]
40. Identifying needs and opportunities for advancing translational research in cardiovascular disease.
Sipido KR; Tedgui A; Kristensen SD; Pasterkamp G; Schunkert H; Wehling M; Steg PG; Eisert W; Rademakers F; Casadei B; Fuster V; Cerbai E; Hasenfuss G; Fernandez-Aviles F; Garcia-Dorado D; Vidal M; Hallen M; Dambrauskaite V
Cardiovasc Res; 2009 Aug; 83(3):425-35. PubMed ID: 19502281
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
